Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-02

Clinical Trial Update: High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high-dose statin plus telmisartan versus amlodipine evaluating effects on glucose metabolism in patients with atherosclerotic cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Statin (high-dose) (statin)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: Yuhan Corporation | Conditions: ASCVD, Impaired Fasting Glucose | Phase 4 | Status: COMPLETED